Loading company…
Riskpilot
← Back to search
Sign in
Get full access
HemmaBäst Hälsa och Sjukvård AB
AB
In liquidation
Org 5591438451
Sjöflygvägen 6
Medical specialists activities · NACE 8622
Est. 2018
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 874
-99% vs 2023
EBITDA margin
-3940.8%
-131% vs 2023
Equity ratio
79.0%
Financial strength
Net profit 2024
SEK 124K
+39% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 874
-99%
EBITDA
SEK -34K
-131%
Net profit
SEK 124K
+39%
Total assets
SEK 264K
-50%
Equity
SEK 209K
-25%
Employees
1
—
Company information
Legal name
HemmaBäst Hälsa och Sjukvård AB
Org number
5591438451
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
4 januari 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
konsult inom hälsa och sjukvård
Contact
Address
Sjöflygvägen 6
Email
a.huseyni@reakconsulting.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
441
384
244
156
1
Staff expenses
—
—
—
−0
−0
EBITDA
316
292
164
112
−34
Depreciation & amort.
−0
−0
—
—
—
EBIT
316
292
164
112
−34
Net financials
—
—
0
2
−97
Profit before tax
237
292
164
114
159
Tax
−51
−60
−34
−24
−35
Net profit
186
232
131
90
124
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
721
777
662
528
264
Equity
376
431
378
279
209
Long-term debt
0
0
—
—
—
Short-term debt
54
55
−6
−42
55
Total debt
54
55
−6
−42
55
Financial ratios
5-year trend
EBITDA margin
-3940.8%
This company
15.8%
Market median
-25042% vs market
2020
2024
Equity ratio
79.0%
This company
38.2%
Market median
+107% vs market
2020
2024
Return on equity
59.6%
This company
18.4%
Market median
+224% vs market
2020
2024
Net profit margin
14208.6%
This company
8.1%
Market median
+175315% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AA
Ahliman Alex Huseyni
Liquidator
Liquidator
2026
Board of directors
Non-executive oversight
Name
Role
Member since
Former (2)
AJ
Ann Jessica Fryckstedt
Board of Directors
2022 – 2026
LK
Leni Katarina Günther
Deputy Board Member
2022 – 2026
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of HemmaBäst Hälsa och Sjukvård AB also hold positions in
0
other companies.
Person
Role here
Other companies
Ahliman Alex Huseyni
Liquidator
0 companies
Ann Jessica Fryckstedt
Board of Directors
0 companies
Leni Katarina Günther
Deputy Board Member
0 companies